The Patent Finder

BioCis Pharma Oy

Also on record
Records under this name other than patents BioCis Pharma Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to BioCis Pharma Oy

PatentTitleStatus Expires Confidence
US 8,673,280Pharmaceutical composition for intracellar acidification with cis-urocanic acid
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
US 8,673,281Pharmaceutical composition for intracellular acidification with cis-urocanic acid
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
US 8,338,475Anti-proliferative pharmaceutical composition
Lapsed on the fee record
Ended Dec 25, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2020From the USPTO record
US 8,313,738Pharmaceutical composition for intracellular acidification with cis-urocanic acid
Lapsed on the fee record
Ended Nov 20, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 20, 2020From the USPTO record
US 5,455,036Method of using cis-urocaninic acid for topically treating psoriasis
Term ended
Term ended no later than Oct 3, 2015 · Low confidence
Term endedTerm ended no later than Oct 3, 2015Low confidence
US 5,494,676Dermatological compositions containing CIS-urocaninic acid
Term ended
Term ended no later than Feb 27, 2016 · Low confidence
Term endedTerm ended no later than Feb 27, 2016Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited